DJIA 16,419.36 -5.49 -0.03%
NASDAQ 4,100.66 14.44 0.35%
S&P 500 1,865.57 3.26 0.18%
market minute promo

company name or ticker

US Futures Point Higher After Sell-Off Even as Emerging Market Rout Continues

5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains this past week.

This Week in Biotech: Clinical Success, Plus Wheeling and Dealing

Two positive clinical results, a symbiotic asset deal, and a rumored takeover target are this week's top stories in Part 2 of "This Week in Biotech."

3 Humongous Health-Care Stocks This Week

Why Ariad, Prana, and Geron enjoyed humongous gains this week.

Why BioDelivery Sciences, Ariad Pharmaceuticals, and Juniper Networks Are Today's 3 Best Stocks

The S&P 500 dives more than 2% on domestic and overseas growth concerns, while BioDelivery Sciences, Ariad Pharmaceuticals, and Juniper Networks buck the trend in a big way.

Market Wrap For January 24: Fear Is Back In The Markets

Ariad Shares Continue to Surge Amidst Buyout Rumors

Why Ariad Pharmaceuticals Inc. Shares Soared

The rumor mill is working overtime today on Ariad Pharmaceuticals thanks to a London newspaper article. Should shareholders jump or balk at this report?

Analyst Reason No. 345 to Upgrade Biotech Stocks: Takeover Rumors in the Foreign Press!

Ariad Pharmaceuticals (ARIA) Surges: Stock Moves 12.1% Higher - Tale of the Tape